How does research and development intensity influence the performance of firms through different stages in product life cycle?
DOI:
https://doi.org/10.1108/inmr-03-2022-0031Palavras-chave:
Artificial intelligence, Alignment, Model, Applicability, InsuranceResumo
PurposeIt is widely acknowledged that the ability of a firm to develop and exploit their innovative capabilities is a critical determinant that maintains their competitive advantage. The purpose is to evaluate the research and development (R&D) inputs and outcomes on the performance of firms in different stages.
Design/methodology/approachDrawing on a sample of 30 firms over 8 years (2009–2016), the results from a three-stage Bayesian stochastic frontier analysis model support were used.
FindingsSome interesting findings were discovered. First, the R&D intensity is positively associated with the number of patents granted, which is negatively associated with the number of new drug approvals (NDAs). Second, R&D inputs, including expenditures and human resources, are negatively related to the number of NDAs and firm performance. Third, state-owned firms perform better and have more patents granted than private-owned firms in China. Finally, the traditional Chinese medicine firms and non-coastal firms both gain fewer profits, but they generate more new drugs than chemical drug firms and coastal firms in terms of policy support.
Originality/valueIt is revealed that there are no common factors among Chinese pharmaceutical firms except for ownership, and this heterogeneous behavior indicates that there is no common factor for enhancing the efficiency of all Chinese pharmaceutical firms.
Downloads
Referências
Alavi, M., & Leidner, D. E. (2001). Review: Knowledge management and knowledge management systems: Conceptual foundations and research issues. MIS Quarterly, 25(1), 107–36. doi: 10.2307/3250961.
Ang, J. S., & Ding, D. K. (2006). Government ownership and the performance of government-linked companies: The case of Singapore. Journal of Multinational Financial Management, 16(1), 64–88. doi: 10.1016/j.mulfin.2005.04.010.
Artz, K. W., Norman, P. M., Hatfield, D. E., & Cardinal, L. B. (2010). A longitudinal study of the impact of R&D, patents, and product innovation on firm performance. Journal of Product Innovation Management, 27(5), 725–40. doi: 10.1111/j.1540-5885.2010.00747.x.
Assaf, A. G., Oh, H., & Tsionas, M. (2017). Bayesian approach for the measurement of tourism performance: A case of stochastic frontier models. Journal of Travel Research, 56(2), 172–86. doi: 10.1177/0047287516633528.
Belderbos, R., Leten, B., & Suzuki, S. (2013). How global is R&D? Firm-Level determinants of home-country bias in R&D. Journal of International Business Studies, 44(8), 765–86. doi: 10.1057/jibs.2013.33.
Bennett, B., Bettis, J. C., Gopalan, R., & Milbourn, T. (2017). Compensation goals and firm performance. Journal of Financial Economics, 124(2), 307–30. doi: 10.1016/j.jfineco.2017.01.010.
Bertrand-Cloodt, D., Hagedoorn, J., & Van Kranenburg, H. (2011). The strength of R&D network ties in high-tech sectors – a multi-dimensional analysis of the effects of tie strength on innovation performance. Technology Analysis and Strategic Management, 23(10), 1015–30. doi: 10.1080/09537325.2011.621294.
Bettis, R. A., & Hitt, M. A. (1995). The new competitive landscape. West sussex. Strategic Management Journal, 16(1), 7–19. doi: 10.1002/smj.4250160915.
Boateng, A., Bi, X. G., & Brahma, S. (2017). The impact of firm ownership, board monitoring on operating performance of Chinese mergers and acquisitions. Review of Quantitative Finance and Accounting, 49(4), 925–48. doi: 10.1007/s11156-016-0612-y.
Bogner, W. C., & Pratima, B. (2007). Knowledge management as the basis of sustained high performance. Journal of Management Studies, 44(1), 165–88. doi: 10.1111/j.1467-6486.2007.00667.x.
Boso, N., Donbesuur, F., Bendega, T., Annan, J., & Adeola, O. (2017). Does organizational creativity always drive market performance?. Psychology and Marketing, 34(11), 1004–15. doi: 10.1002/mar.21039.
Broeck, J. V. D., Koop, G., Osiewalski, J., & Steel, M. F. J. (1992). Stochastic frontier models ☆: A bayesian perspective. Journal of Econometrics, 61(2), 273–303. doi: 10.1016/0304-4076(94)90087-6.
Buck, T., Filatotchev, I., Wright, M., & Zhukov, V. (1999). Corporate governance and employee ownership in an economic crisis: Enterprise strategies in the former USSR. Journal of Comparative Economics, 27(3), 459–74. doi: 10.1006/jcec.1999.1606.
Chen, Y.-S., & Chang, K.-C. (2010). Exploring the nonlinear effects of patent citations, patent share and relative patent position on market value in the US pharmaceutical industry. Technology Analysis and Strategic Management, 22(2), 153–69. doi: 10.1080/09537320903498496.
Dai, Y., Li, M., & Zhang, T. (2013). Innovation performance of Chinese pharmaceutical industry patents based on fuzzy comprehensive evaluation. Journal of Investigative Medicine, 61(4), S26–S7.
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20–33. doi: 10.1016/j.jhealeco.2016.01.012.
Federsel, H.-J. (2010). Process R&D under the magnifying glass: Organization, business model, challenges, and scientific context. Bioorganic and Medicinal Chemistry, 18(16), 5775–94. doi: 10.1016/j.bmc.2010.06.029.
Geweke, J. (1991). Evaluating the accuracy of sampling-based approaches to the calculation of posterior moments. Staff Report, 4, 169–93.
Grant, R. M. (1996). Toward a knowledge-based theory of the firm. Strategic Management Journal, 17(2), 109–22. doi: 10.1002/smj.4250171110.
Griffin, J. E., & Steel, M. F. J. (2007). Bayesian stochastic frontier analysis using WinBUGS. Journal of Productivity Analysis, 27(3), 163–76. doi: 10.1007/s11123-007-0033-y.
Hinkin, T. R., & Bruce Tracey, J. (2010). What makes it so great? An analysis of human resources practices among fortune's best companies to work for. Cornell Hospitality Quarterly, 51(2), 158–70. doi: 10.1177/1938965510362487.
Jensen, P. H., Thomson, R., & Yong, J. S. (2011). Estimating the patent premium: Evidence from the Australian inventor survey. Strategic Management Journal, 32(10), 1128–38. doi: 10.1002/smj.925.
Jeon, J., Hong, S., Ohm, J., & Yang, T. (2015). Causal relationships among technology acquisition, absorptive capacity, and innovation performance: Evidence from the pharmaceutical industry. PLoS One, 10(7), e0131642. doi: 10.1371/journal.pone.0131642.
Jin, X., Lei, G., & Yu, J. (2016). Government governance, executive networks and enterprise R&D Expenditure. China Journal of Accounting Research, 9(1), 59–81. doi: 10.1016/j.cjar.2015.09.001.
Katsikeas, C. S., Morgan, N. A., Leonidou, L. C., & Hult, G. T. M. (2016). Assessing performance outcomes in marketing. Journal of Marketing, 80(2), 1–20. doi: 10.1509/jm.15.0287.
Kehoe, R. R., & Wright, P. M. (2013). The impact of high-performance human resource practices on employees' attitudes and behaviors. Journal of Management, 39(2), 366–91. doi: 10.1177/0149206310365901.
King, D. R., Slotegraaf, R. J., & Kesner, I. (2008). Performance implications of firm resource interactions in the acquisition of R&D-Intensive firms. Organization Science, 19(2), 327–40. doi: 10.1287/orsc.1070.0313.
Li, X., & Hamblin, D. (2016). Factors impacting on cleaner production: Case studies of Chinese pharmaceutical manufacturers in Tianjin, China. Journal of Cleaner Production, 131, 121–32. doi: 10.1016/j.jclepro.2016.05.066.
Li, J., Chen, D., & Shapiro, D. M. (2010). Product innovations in emerging economies: The role of foreign knowledge access channels and internal efforts in Chinese firms. Management and Organization Review, 6(2), 243–66. doi: 10.1111/j.1740-8784.2009.00155.x.
Li, F., Yu, K. F., Yang, J., Qi, Z., & Ho-ying Fu, J. (2014). Authentic leadership, traditionality, and interactional justice in the Chinese context. Management and Organization Review, 10(2), 249–73. doi: 10.1111/more.12027.
Lukas, B. A., & Ferrell, O. C. (2000). The effect of market orientation on product innovation. Journal of the Academy of Marketing Science, 28(2), 239–47. doi: 10.1177/0092070300282005.
Malshe, A., & Biemans, W. (2014). The role of sales in NPD: An investigation of the US health-care industry. Journal of Product Innovation Management, 31(4), 664–79. doi: 10.1111/jpim.12159.
Ministry of Commerce of People's Republic of China (2016). Statistical Analysis Report on the Operation of Drug Circulation Industry in 2016, Ministry of Commerce of People's Republic of China.
Morgan, N. A., Slotegraaf, R. J., & Vorhies, D. W. (2009). Linking marketing capabilities with profit growth. International Journal of Research in Marketing, 26(4), 284–93. doi: 10.1016/j.ijresmar.2009.06.005.
Peng, H., Duysters, G., & Sadowski, B. (2016). The changing role of guanxi in influencing the development of entrepreneurial companies: A case study of the emergence of pharmaceutical companies in China. The International Entrepreneurship and Management Journal, 12(1), 215–58. doi: 10.1007/s11365-014-0323-6.
Ramaswamy, K., Li, M., & Veliyath, R. (2002). Variation in ownership behavior and propensity to diversify: A study of the Indian context. Strategic Management Journal, 23(4), 345–58. doi: 10.1002/smj.227.
Rogers, M. (2004). Networks, firm size and innovation. Small Business Economics, 22(2), 141–53. doi: 10.1023/b:sbej.0000014451.99047.69.
Scannell, J. W., & Bosley, J. (2016). When quality beats quantity: Decision theory, drug discovery, and the reproducibility crisis. PLoS One, 11(2), 21. doi: 10.1371/journal.pone.0147215.
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012). Diagnosing the decline in pharmaceutical R&D efficiency. Nature Reviews Drug Discovery, 11(3), 191–200. doi: 10.1038/nrd3681.
Shen, W., Zhou, Q., & Lau, C.-M. (2016). Empirical research on corporate governance in China: A review and new directions for the future. Management and Organization Review, 12(1), 41–73. doi: 10.1017/mor.2015.11.
Situmeang, F. B. I., Leenders, M., & Wijnberg, N. M. (2017). New product performance and the benefit of periodically changing the relative influence balance between marketing and R&D. Journal of Business and Industrial Marketing, 32(1), 180–91. doi: 10.1108/jbim-01-2015-0020.
Song, X. M., MontoyaWeiss, M. M., & Schmidt, J. B. (1997). Antecedents and consequences of cross-functional cooperation: A comparison of R&D, manufacturing, and marketing perspectives. Journal of Product Innovation Management, 14(1), 35–47. doi: 10.1111/1540-5885.1410035.
Tellis, G. J., Prabhu, J. C., & Chandy, R. K. (2009). Radical innovation across nations: The preeminence of corporate culture. Journal of Marketing, 73(1), 3–23. doi: 10.1509/jmkg.73.1.3.
Tsionas, E. G., & Kumbhakar, S. C. (2014). Firm heterogeneity, persistent and transient technical inefficiency: A generalized true random-effects model. Journal of Applied Econometrics, 29(1), 110–32. doi: 10.1002/jae.2300.
Vorhies, D. W., & Morgan, N. A. (2005). Benchmarking marketing capabilities for sustainable competitive advantage. Journal of Marketing, 69(1), 80–94. doi: 10.1509/jmkg.69.1.80.55505.
Wang, K.-J., & Lestari, Y. D. (2013). Firm competencies on market entry success: Evidence from a high-tech industry in an emerging market. Journal of Business Research, 66(12), 2444–50. doi: 10.1016/j.jbusres.2013.05.033.
Xu, S. (2015). Balancing the two knowledge dimensions in innovation efforts: An empirical examination among pharmaceutical firms. Journal of Product Innovation Management, 32(4), 610–21. doi: 10.1111/jpim.12234.
Zhou, S. J., & Zhou, A. J. (2017). Research potential on innovation in India and China. Management and Organization Review, 13(2), 447–9. doi: 10.1017/mor.2017.15.
Zhu, H. (2008). Defects in the medical system and distortion in drug pricing. Social Sciences in China, 29(01), 50–65. doi: 10.1080/02529200801920806.
Ziyae, B. (2016). Presenting an evaluation model of human resource management's effect on corporate entrepreneurship. Journal of Organisational Studies and Innovation, 3(2), 1–15. doi: 10.1108/wjemsd-03-2016-0013.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2025 Dan Li
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
• O(s) autor(es) autoriza(m) a publicação do artigo na revista;
• O(s) autor(es) garante(m) que a contribuição é original e inédita e que não está em processo de avaliação em outra(s) revista(s);
• A revista não se responsabiliza pelas opiniões, ideias e conceitos emitidos nos textos, por serem de inteira responsabilidade de seu(s) autor(es);
• É reservado aos editores o direito de proceder ajustes textuais e de adequação do artigos às normas da publicação.
